BRCA1 and ovarian serous adenocarcinoma: In high-grade serous ovarian cancer (HGSOC), pathogenic germline variants and somatic BRCA1/2 mutations can be found in 17–25% of patients, and 18–30% of all BRCA1/2 variations are somatic in origin [41, 86, 87].